Proxy Vote

Genmab A/S

March 13, 2026 11:59 PM  •  Author: Phil Ratcliff
Proxy Materials:

2: Presentation and adoption of the audited Annual Report and discharge of Board of Directors and Executive ManagementFor (849.539)
3: Resolution on the distribution of profits as recorded in the adopted Annual ReportFor (849.539)
4: Advisory vote on the Compensation ReportFor (849.539)
5: Election of members of the Board of Directors:
5a: Re-election of Deirdre P. ConnellyFor (849.539)
5b: Re-election of Pernille ErenbjergFor (849.539)
5c: Re-election of Rolf HoffmannFor (849.539)
5d: Re-election of Elizabeth O’FarrellFor (849.539)
5e: Re-election of Dr. Paolo PaolettiFor (849.539)
5f: Re-election of Dr. Anders Gersel PedersenAbstain (849.539)
6: Election of auditor: Re-election of Deloitte Statsautoriseret RevisionspartnerselskabFor (849.539)
7: Proposals from the Board of Directors:
7a: Approval of remuneration to the Board of Directors for 2026For (849.539)
7b: Proposal to reduce the Company’s share capital for the purpose of cancelling treasury sharesFor (849.539)
8: Authorization of the Chair of the General Meeting to register resolutions passed by the General MeetingFor (849.539)

This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.